Chicago Capital Management, LLC

Q2 2025 13F Combination Report, Stock Holdings

Signature - Title
Steven Gerbel - Managing Member
Location
Chicago, IL
Holdings as of
30 Jun 2025
Value $
$116,811,520
Num holdings
40
Filing time
07 Aug 2025, 12:09:10 UTC
Form type
13F-HR
Description
A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s). Top holdings included SWTX, CARDLYTICS INC, EVENTBRITE INC, BPMC, and ESPERION THERAPEUTICS INC NE.
Previous filing
Q1 2025 - 09 May 2025
Next filing
Q3 2025 - 07 Nov 2025
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2025 Q2 compared to 2025 Q1 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Steven Gerbel Managing Member Chicago, Illinois 06 Aug 2025

List of Other Managers Reporting for Chicago Capital Management, LLC:

Name Holdings Value Location File Number
PRELUDE CAPITAL MANAGEMENT, LLC $1,357,617,891 New York, NY 028-12257

Other Included Managers (1):

Num Name Location File Number
1 PRELUDE CAPITAL MANAGEMENT, LLC New York, NY 028-12257